Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy

Shahid M Chandna, Maria Da Silva-Gane, Catherine Marshall, Paul Warwicker, Roger N Greenwood, Ken Farrington, Shahid M Chandna, Maria Da Silva-Gane, Catherine Marshall, Paul Warwicker, Roger N Greenwood, Ken Farrington

Abstract

Background: Elderly patients with end-stage renal disease and severe extra-renal comorbidity have a poor prognosis on renal replacement therapy (RRT) and may opt to be managed conservatively (CM). Information on the survival of patients on this mode of therapy is limited.

Methods: We studied survival in a large cohort of CM patients in comparison to patients who received RRT.

Results: Over an 18-year period, we studied 844 patients, 689 (82%) of whom had been treated by RRT and 155 (18%) were CM. CM patients were older and a greater proportion had high comorbidity. Median survival from entry into stage 5 chronic kidney disease was less in CM than in RRT (21.2 vs 67.1 months: P < 0.001). However, in patients aged > 75 years when corrected for age, high comorbidity and diabetes, the survival advantage from RRT was ~ 4 months, which was not statistically significant. Increasing age, the presence of high comorbidity and the presence of diabetes were independent determinants of poorer survival in RRT patients. In CM patients, however, age > 75 years and female gender independently predicted better survival.

Conclusions: In patients aged > 75 years with high extra-renal comorbidity, the survival advantage conferred by RRT over CM is likely to be small. Age > 75 years and female gender predicted better survival in CM patients. The reasons for this are unclear.

Figures

Fig. 1
Fig. 1
Kaplan–Meier survival curves from entry into stage 5 CKD for patients treated by RRT (n = 689) and by conservative kidney management (n = 155).
Fig. 2
Fig. 2
Comparison of Kaplan–Meier survival curves by modality (RRT vs conservative kidney management) in patients > 75 years. The panel on the left depicts the relationships in those with low comorbidity and that on the right in those with high comorbidity.
Fig. 3
Fig. 3
Cox proportional model survival curve of patients aged > 75 years—CM vs RRT—adjusted for age, gender, ethnicity, the presence of diabetes and the presence of high comorbidity. Median survival in RRT patients is better by

Fig. 4

Cox proportional model survival curve…

Fig. 4

Cox proportional model survival curve of conservatively managed patients aged > 75 years vs…

Fig. 4
Cox proportional model survival curve of conservatively managed patients aged > 75 years vs younger patients—adjusted for gender, ethnicity, the presence of diabetes, the presence of high comorbidity and eGFR at the start of the study. Survival of older patients is significantly better than that of younger patients (P = 0.009).
Fig. 4
Fig. 4
Cox proportional model survival curve of conservatively managed patients aged > 75 years vs younger patients—adjusted for gender, ethnicity, the presence of diabetes, the presence of high comorbidity and eGFR at the start of the study. Survival of older patients is significantly better than that of younger patients (P = 0.009).

References

    1. Challah S, Wing AJ, Bauer R, et al. Negative selection of patients for dialysis and transplantation in the United Kingdom. Br Med J (Clin Res Ed) 1984;288:1119–1122.
    1. Farrington K, Udayaraj U, Gilg J, et al. UK Renal Registry 11th Annual Report (December 2008): Chapter 3 ESRD incident rates in 2007 in the UK: national and centre-specific analyses. Nephron Clin Pract. 2009;111:c13–c41.
    1. Zoccali C, Kramer A, Jager K. The databases: renal replacement therapy since 1989—the European Renal Association and European Dialysis and Transplant Association (ERA–EDTA) Clin J Am Soc Nephrol. 2009;4:S18–S22.
    1. U S Renal Data System. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2009.
    1. Chandna SM, Schulz J, Lawrence C, et al. Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ. 1999;318:217–223.
    1. Kurella TM, Covinsky KE, Chertow GM, et al. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med. 2009;361:1539–1547.
    1. Hirsch DJ, West ML, Cohen AD, et al. Experience with not offering dialysis to patients with a poor prognosis. Am J Kidney Dis. 1994;23:463–466.
    1. Sekkarie M, Cosma M, Mendelssohn D. Nonreferral and nonacceptance to dialysis by primary care physicians and nephrologists in Canada and the United States. Am J Kidney Dis. 2001;38:36–41.
    1. Singer PA. Nephrologists’ experience with and attitudes towards decisions to forego dialysis. The End-Stage Renal Disease Network of New England. J Am Soc Nephrol. 1992;2:1235–1240.
    1. Smith C, Da Silva-Gane M, Chandna S, et al. Choosing not to dialyse: evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron Clin Pract. 2003;95:c40–c46.
    1. Van BW, Lameire N, Veys N, et al. From curing to caring: one character change makes a world of difference. Issues related to withholding/withdrawing renal replacement therapy (RRT) from patients with important co-morbidities. Nephrol Dial Transplant. 2004;19:536–540.
    1. Murtagh FE, Marsh JE, Donohoe P, et al. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant. 2007;22:1955–1962.
    1. Carson RC, Juszczak M, Davenport A, et al. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol. 2009;4:1611–1619.
    1. Wong CF, McCarthy M, Howse ML, et al. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis. Ren Fail. 2007;29:653–659.
    1. Ellam T, El-Kossi M, Prasanth KC, et al. Conservatively managed patients with stage 5 chronic kidney disease—outcomes from a single center experience. QJM. 2009;102:547–554.
    1. De Biase V, Tobaldini O, Boaretti C, et al. Prolonged conservative treatment for frail elderly patients with end-stage renal disease: the Verona experience. Nephrol Dial Transplant. 2008;23:1313–1317.
    1. Joly D, Anglicheau D, Alberti C, et al. Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol. 2003;14:1012–1021.
    1. Roberts SB, Dallal GE. Effects of age on energy balance. Am J Clin Nutr. 1998;68:975S–979S.
    1. Singer MA. Of mice and men and elephants: metabolic rate sets glomerular filtration rate. Am J Kidney Dis. 2001;37:164–178.
    1. Paul DR, Novotny JA, Rumpler WV. Effects of the interaction of sex and food intake on the relation between energy expenditure and body composition. Am J Clin Nutr. 2004;79:385–389.
    1. Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med. 2009;6:60–75.
    1. Poggio ED, Rule AD, Tanchanco R, et al. Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors. Kidney Int. 2009;75:1079–1087.
    1. Lameire N, Wauters JP, Teruel JL, et al. An update on the referral pattern of patients with end-stage renal disease. Kidney Int Suppl. 2002:27–34.
    1. Dasgupta I, Rayner HC. In good conscience—safely withholding dialysis in the elderly. Semin Dial. 2009;22:476–479.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する